FR2414334A2 - Compositions pharmaceutiques contenant comme ingredient actif la d-2-bromo-1,6-dimethyl-8b-(perhydroazepinylcarbonyloxymethyl)-ergoline, utile notamment pour le traitement des troubles d'origine psychogene - Google Patents

Compositions pharmaceutiques contenant comme ingredient actif la d-2-bromo-1,6-dimethyl-8b-(perhydroazepinylcarbonyloxymethyl)-ergoline, utile notamment pour le traitement des troubles d'origine psychogene

Info

Publication number
FR2414334A2
FR2414334A2 FR7826150A FR7826150A FR2414334A2 FR 2414334 A2 FR2414334 A2 FR 2414334A2 FR 7826150 A FR7826150 A FR 7826150A FR 7826150 A FR7826150 A FR 7826150A FR 2414334 A2 FR2414334 A2 FR 2414334A2
Authority
FR
France
Prior art keywords
perhydroazepinylcarbonyloxymethyl
ergoline
bromo
dimethyl
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR7826150A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siphar SA
Original Assignee
Siphar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siphar SA filed Critical Siphar SA
Publication of FR2414334A2 publication Critical patent/FR2414334A2/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Le composé selon l'invention contient comme ingrédient actif la D-2-bromo-1,6-diméthyl-8 beta -(perhydroazépinylcarbonyloxyméthyl)-ergoline de formule :
FR7826150A 1978-01-17 1978-09-12 Compositions pharmaceutiques contenant comme ingredient actif la d-2-bromo-1,6-dimethyl-8b-(perhydroazepinylcarbonyloxymethyl)-ergoline, utile notamment pour le traitement des troubles d'origine psychogene Pending FR2414334A2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH48378A CH632162A5 (it) 1978-01-17 1978-01-17 Composizione farmaceutica, utile per il trattamento di disordini di origine psicogena.

Publications (1)

Publication Number Publication Date
FR2414334A2 true FR2414334A2 (fr) 1979-08-10

Family

ID=4188032

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7826150A Pending FR2414334A2 (fr) 1978-01-17 1978-09-12 Compositions pharmaceutiques contenant comme ingredient actif la d-2-bromo-1,6-dimethyl-8b-(perhydroazepinylcarbonyloxymethyl)-ergoline, utile notamment pour le traitement des troubles d'origine psychogene

Country Status (5)

Country Link
JP (1) JPS54100395A (fr)
BE (1) BE870487R (fr)
CH (1) CH632162A5 (fr)
FR (1) FR2414334A2 (fr)
GB (1) GB2012164A (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2303548A1 (fr) * 1975-03-14 1976-10-08 Siphar Sa Nouveaux carbamates de 2-halogenoergolines et 2-halogenoergolenes, utiles notamment comme vasodilatateurs, et leur procede de preparation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2303548A1 (fr) * 1975-03-14 1976-10-08 Siphar Sa Nouveaux carbamates de 2-halogenoergolines et 2-halogenoergolenes, utiles notamment comme vasodilatateurs, et leur procede de preparation

Also Published As

Publication number Publication date
CH632162A5 (it) 1982-09-30
JPS54100395A (en) 1979-08-08
GB2012164A (en) 1979-07-25
BE870487R (fr) 1979-01-02

Similar Documents

Publication Publication Date Title
FR2430410A1 (fr) Phenethanolamines et compositions pharmaceutiques en contenant
FR2356424A1 (fr) Compositions pharmaceutiques a base d'acide phophono-formique utiles pour lutter contre les infections virales
MA27774A1 (fr) Inhibiteurs de phosphatidylinositol 3-kinase
MA31894B1 (fr) Composes organiques
FR2435471A1 (fr) Derives de dihydropyridine, procedes d'obtention et compositions pharmaceutiques en contenant
NO170280C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfamatderivater
FR2430412A1 (fr) Derives substitues de propanolamine utiles comme medicaments et procede de leur preparation
MA26697A1 (fr) Composes nouveaux inhibiteurs de gsk-3 et compositions pharmaceutiques les contenant
FR2391723A1 (fr) Composition therapeutique a base de cetone aliphatique pour le traitement des ulceres peptiques
BE903183A (fr) Nouveaux derives du benzonorbornene, leurs procedes de preparation et composition medicamenteuse et cosmetique les contenant
ES2038172T3 (es) Procedimiento para preparar carboxamidas heterociclicas.
FR2397403A1 (fr) Nouveaux derives de 1-acyl 2-cyano-aziridine, procede pour leur preparation et compositions pharmaceutiques contenant ces composes
FR2422657A1 (fr) 2-(2-thenoylthio)-propionylglycine, procede pour sa preparation et compositions pharmaceutiques la contenant
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
FR2393577A1 (fr) Medicament a base d'acide b-(p-halogenophenyl)-g-aminobutyrique destine au traitement de la nevrose d'angoisse
FR2405067A1 (fr) Compositions pharmaceutiques contenant des derives monofonctionnels du psoralene pour le traitement des affections cutanees
NO158379C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroalifatiske forbindelser.
FR2420344A1 (fr) Nouveaux oxime-ethers, leur preparation et leur application therapeutique.
FR2428436A1 (fr) Nouvelles compositions cosmetiques pour le traitement de l'etat gras des cheveux et de la peau, composes nouveaux et leur procede de preparation
ATE110568T1 (de) Pharmazeutisches präparat zur behandlung des katarakts.
FR2414334A2 (fr) Compositions pharmaceutiques contenant comme ingredient actif la d-2-bromo-1,6-dimethyl-8b-(perhydroazepinylcarbonyloxymethyl)-ergoline, utile notamment pour le traitement des troubles d'origine psychogene
FR2378757A1 (fr) Nor-o-heterocyclo-dehydro-13, 14 prostaglandines, leur procede de preparation et leur application comme medicaments
FR2440353A1 (fr) Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament
FR2442239A1 (fr) Procede de preparation de 4,l-benzoxazepines et de leur analogue thia, nouveaux produits ainsi obtenus et leur utilisation pour le traitement de troubles mentaux
MA26734A1 (fr) Derives de 1-trifluoromethyl -4-hydroxy- 7-piperidinyl- aminomethylchromane, procede pour leur preparation et compositions pharmaceutiques les contenant